TREATMENT FOR CHLAMYDIA INFECTION IN GYNECOLOGY AND OBSTETRICS: A REVIEW OF CURRENT FOREIGN AND RUSSIAN GUIDELINES


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The review deals with the treatment of infection caused by Chlamydia trachomatis in obstetric and gynecological care, considers antimicrobial drugs and therapy regimens, which are given in the current foreign and Russian guidelines for the treatment of urogenital Chlamydia infection in nonpregnant and pregnant patients, and analyzes the data of clinical trials of the efficacy and safety of recommended antibiotics.

Texto integral

Acesso é fechado

Sobre autores

V. KISINA

I.M. Sechenov First Moscow State Medical University

Email: Kisina2005@yandex.ru
Department of Skin and Venereal Diseases, Faculty for Advanced Professional Education Moscow

I. ANDREYEVA

Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical Academy, Ministry of Health and Social Development of Russia

Smolensk

O. STETSYUK

Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical Academy, Ministry of Health and Social Development of Russia

Smolensk

Bibliografia

  1. Берлев И.В., Тестова Г.В. Лечение урогенитального хламидиоза у беременных // Инфекции в хирургии. - 2003. - № 1. -С. 4.
  2. Глазкова Л.К., Герасимова Н.М. Терешина Л.П. Опыт клинического применения ровамицина в терапии беременных с урогенитальной хламидийной инфекцией. Вестник дерматологии и венерологии. 1997; 5: 75—6.
  3. Евсюкова Н.Н., Кошелева Н.Г., Башлякова М.М. Хламидийная инфекция в акушерстве и перинатологии. - СПб., 1995.
  4. Качалина Т.С., Каткова Н.Ю. Выбор препарата для антибактериальной терапии хламидийной, микоплазменной и уреаплазменной инфекций у беременных // Вестник Российской ассоциации дерматовенерологов. - 2001. - № 2. - С. 76-80.
  5. Кисина В.И. Отечественная и международная практика лечения хламидийной инфекции у беременных с позиции доказательной медицины // Гинекология. - 2010. -№ 4. - С. 8-13.
  6. Клинические рекомендации. Акушерство и гинекология. / Под ред. Г.М. Савельевой, В.Н. Серова, Г.Т. Сухих. 3-е изд., испр. и доп. - М.: ГЭОТАР-Медиа, 2009. -880 с.
  7. Протокол ведения больных «Инфекции, передаваемые половым путем». «Урогенитальная хламидийная инфекция». / Под ред. В.И. Кисиной. - М.: Ньюдиамед, 2011. - С. 164-191.
  8. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. / Под ред. В.Н. Серова, Г.Т. Сухих. - М.: Литтерра, 2010.
  9. Российское общество дерматовенерологов. Инфекции, передаваемые половым путем. Клинические рекомендации. Дерматовенерология. / Под ред. А.А. Кубановой. - М.: ДЭКС-Пресс. - 2010. - 428 с.
  10. Савичева А.М., Башмакова М.А. Урогенитальный хламидиоз у женщин и его последствия. - М.: Медицинская книга. - 1998. - С. 65-87.
  11. Справочник Видаль «Лекарственные препараты в России» 2011. Вильпрафен. http://www.vidal.ru/poisk_ preparatov/wilprafen.htm.
  12. Юцковский А.Д., Юцковская Я.А., Ивашков Е.А. К проблеме урогенитальных инфекций у беременных: опыт лечения вильпрафеном // Российский журнал кожных и венерических болезней. - 2002. - № 6. - С. 67-70.
  13. Alary M., Loey J.R., Moutquih J.M. et al. Randomized prospective study comparing erythromycin and amoxycillin in the treatment of genital chlamydial infection in pregnancy // Lancet. - 1994. - № 344 - Р. 1461-1465.
  14. Andrews W.W., Goldenberg R.L., Mercer B. et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth // Am. J. Obstet. Gynecol. - 2000. - № 183. - Р. 662-668.
  15. Baud D., Regan L., Greub G. Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes // Curr. Opin. Infect. Dis. - 2008. - № 21. -Р. 70-76.
  16. Brocklehurst P., Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy (Cochrane Review). / In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
  17. Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases // MMWR. - 2002. - Vol. 51, № 6. - Р. 34.
  18. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2006. MMWR 2006; 55 (№ RR-11).
  19. Chen M.Y., Fairley C.K., De Guingand D. et al. Screening pregnant women for chlamydia: what are the predictors of infection? // Sex Transm. Infect. - 2009. - № 85. - Р. 31-35.
  20. Cohen I., Veille J.C., Calkins B.M. Improved pregnancy outcome following successful treatment of chlamydial infection // JAMA. - 1990. - № 263. - Р. 3160-3163.
  21. Czeizel A.E., Rockenbauer M., Olsen J., S0rensen H.T. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin // Acta. Obstet. Gynecol. Scand. - 2000. - Vol. 79, № 3. -Р. 234-237.
  22. Dylewski J., Clecner B., Dubois J. et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections // Antimicrob. Agents Chemother. - 1993. - Vol. 37, № 6. - Р. 1373-1374.
  23. Kallen B.A.J., Otterblad Olausson P., Danielsson B.R. Is erythromycin therapy teratogenic in humans? // Reprod. Toxicol. - 2005. - № 20. - Р. 209-214.
  24. Kovacs L., Nagy E., Berbik I. et al. The frequency and the role of Chlamydia trachomatis infection in premature labor. Int. J. Gynaecol. Obstet. 1998; 62: 47-54.
  25. Land J.A., Van Bergen J.E.A.M., Morre S.A., Postma M.J. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening // Human. Reproduction Update. - 2010. - Vol. 16, № 2. -Р. 189-204.
  26. Lanjouw E., Ossewaarde J.M., Stary A. et al. 2010 European guideline for the management of Chlamydia trachomatis infections // Int. J. STD AIDS. - 2010. - Vol. 21, № 11. -Р. 729-737.
  27. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials // Sex. Transm. Dis. - 2002. - Vol. 29, № 9. -Р. 497-502.
  28. Macaluso M., Wright-Schnapp T.J., Chandra A., et al. A public health focus on infertility prevention, detection, and management // Fertil. Steril. - 2010. - Vol. 93, № 16. -Р. 1-10.
  29. Magat A.H., Alger L.S., Nagey D.A. et al. Doubleblinded randomized study comparing amoxicillin and erythromycin for treatment of Chlamydia trachomatis in pregnancy // Obstet. Gynecol. - 1993. - № 81. -Р. 745-749.
  30. Miller J.M., Martin D.H. Treatment of Chlamydia trachomatis infections in pregnant women // Drugs. - 2000. - Vol. 60, № 3. -Р. 597-605.
  31. Miller Jr.J.M. Efficacy and tolerance of single-dose azithromycin for treatment of chlamydial cervicitis during pregnancy // Infect. Dis. Obstet. Gynecol. - 1995. - № 3. -Р. 189-192.
  32. Mullick S., Watson-Jones D., Beksinska M. et al. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries // Sex. Trans. Infect. - 2005. -№ 81. - Р. 294-302.
  33. No authors listed. CDC Grand Rounds: Chlamydia // MMWR Morb. Mortal. Wkly Rep. - 2011. - Vol. 60, № 12. - Р. 370-373.
  34. Peipert J.F. Genital chlamydial infections // N. Engl. J. Med. - 2003. - № 349. - Р. 2424-2430.
  35. Pitsouni E., Iavazzo C., Athanasiou S., Falagas M.E. Singledose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a metaanalysis of randomised controlled trials // Int. J. Antimicrob. Agents. - 2007. - Vol. 30, № 3. - Р. 213-221.
  36. Rahangdale L., Guerry S., Bauer H.M. et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy // Sex. Transm. Dis. - 2006. - № 33. -Р. 106-110.
  37. Rastogi S., Kapur S., Salhan S. et al. Chlamydia trachomatis infection in pregnancy: Risk factor for an adverse outcome // Brit. J. Biomed. Scien. - 1999. - № 56. - Р. 94-98.
  38. Simunic V., Vrcic H., Culig J. et al. Single dose of azithromycin in the treatment of sexually transmitted disease in infertile and pregnant women. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996: Söltz-Szöts J., Schneider S., Niebauer B. et al. Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients // Z. Hautkr. - 1989. - Vol. 64. № 2. -Р. 129-131.
  39. Stary A. European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of chlamydial infection // Int. J. STD AIDS. - 2001. - № 12 (Suppl. 3). - Р 30-33.
  40. STDs & Pregnancy - CDC Fact Sheet. Available from: http:// www.cdc.gov/std/pregnancy/STDFact-Pregnancy.htm.
  41. Sutton M., Sternberg M., Zaidi A. et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001 // Sex. Transm. Dis. - 2005. - № 32. - Р 778-784.
  42. US Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. - 2007. -№ 147. - Р 128-134.
  43. van de Laar M.J., Fontaine J. ECDC guidance on chlamydia control in Europe: next steps // Euro Surveill. - 2009. -Vol. 14, № 26. - Р. 19260.
  44. van de Laar M.J., Morré S.A. Chlamydia: a major challenge for public health // Euro Surveill. - 2007. - Vol. 12, № 10. -Р 1-2.
  45. WHO. Prevention and control of sexually transmitted infections: draft global strategy, 2006. Available from: http:// www.who.int/reproductive-health/docs/stis_strategy.pdf.
  46. Workowski K.A., Berman S; Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2010 // MMWR Recomm Rep. - 2010. - 59 (RR-12). - Р 1-10.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2012

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies